Self reported measures of health related quality of life are increasingly used to complement clinical information in clinical research, whereas their usefulness in clinical practice is still debated.' 2 One barrier to more widespread use of such questionnaires is their length;3 consequently, existing questionnaires have been shortened by omission of subscales,4 omission of items, or both. ' 5 However, short forms have inherent weaknesses relative to the longer versions.
The Health Assessment Questionnaire (HAQ)6 is one of the most widely used physical function scales in rheumatic disease. 7 Pincus et al produced the modified HAQ (MHAQ) by reducing the questionnaire from 20 to eight questions' and supplemented the original questions assessing level of difficulty with additional questions assessing patient satisfaction regarding the same activities of daily living-a unique and useful feature. 8 In a cross sectional study the eight items framed in the original 'difficulty' format captured most of the information represented by the 20 HAQ items.' The only study that assessed the difficulty format of the MHAQ longitudinally4 found the MHAQ to be as responsive as the physical dimensions of the Sickness Impact Profile,9 the SF-36,5 the Functional Status Questionnaire,'0 and the short version of the Arthritis Impact Measurement Scale." The study did not compare the responsiveness of the MHAQ with that of the full HAQ, nor did it assess if the questionnaire was sensitive to small but clinically meaningful changes.
The objective of this study was to evaluate whether the difficulty section of the MHAQ is sensitive to clinical changes in ambulatory rheumatoid arthritis (RA) patients. Clinical evaluation included swollen and tender joint count, grip strength (mean of both sides), and muscle strength (muscle strength index: mean of elbow and knee extension and flexor strength of both sides expressed as percentage of the maximal strength in the population.'4 Laboratory assessment included erythrocyte sedimentation rate (ESR) and haemoglobin. Overall disease activity was measured by physician's global assessment with an NRS and two pooled indices (disease activity score (DAS)'5 and Mallya index. '6 Tender joint count was used instead of the Ritchie articular count for both indices (for the calculation of the DAS, the tender count was multiplied by 2).
Methods

ANALYSES
To compare the cross sectional discriminative ability of the MHAQ with that of the full HAQ, we examined the distribution in stem and leaf diagrams at baseline and one year follow up and examined the correlation of the questionnaires with clinical parameters using Spearman's rank correlation coefficient.
To examine if the MHAQ detects clinically meaningful change, we compared the mean change in clinical and laboratory parameters for patients who recorded improved, unchanged, or worse scores at the one year follow up. We hypothesised that patients whose HAQ or MHAQ scores improved would have a decrease in disease activity and pain, and an increase in muscle strength. A significant difference between the change in clinical para- 
Results
One year follow up data were available for 56 of the 62 patients included in the baseline survey; six patients either refused to participate in the follow up or could not be contacted. Findings for the 56 patients with both baseline and follow up data are presented. Sixty one percent of the patients were female; median age was 62 years (25th percentile: 51; 75th percentile: 70) and median disease duration 5-1 years (25th percentile: 1-3; 75th percentile: 107); 57% had a positive rheumatoid factor titre (Singer-Plotz 1:40). All patients were white; 97% graduated from high school, and 64% graduated from college or had professional training. Median MHAQ score was 0-25 (0; 0 75), whereas median HAQ score was 1-19 (0-31; 1-75), which indicates moderate disability. Eighty eight percent of the patients were treated with slow acting drugs, 45% were taking corticosteroids, and 94% were taking non-steroidal antirheumatic drugs. Table 1 shows the baseline clinical characteristics (25th, 50th, and 75th percentile values).
CROSS SECTIONAL ANALYSES
The distributions of both the MHAQ and the HAQ at baseline and at one year follow up were bimodal (table 2). Thirteen percent of patients had an HAQ score of 0 and 32% had a score < 0 3 and clustered in the first mode; the second mode of the HAQ distribution was at 1-4. Twenty nine percent of the patients had an MHAQ score of 0, and 52% had a score <0 3 and clustered in the first mode; the second mode of the MHAQ distribution was at 07.
With the exception of swollen joint count and ESR, there was a significant moderate-tostrong association between the questionnaires and clinical parameters; correlations were slightly lower for the MHAQ ( In a parametric analysis (assuming interval characteristic of the MHAQ) change in MHAQ correlated only with change in pain (r =0-32, p < 0-05), but not with the other external criteria.
Of 16 patients with an MH-IAQ score of 0 at baseline, 10 improved in their Mallya score and reported improvement in the global transition question, but the MHAQ scores stayed the same in six and worsened in four. Of the six patients whose Mallya score worsened and who reported deterioration of their health, five also had a worse MHAQ score and only one still had a score of 0 at one year follow up. These findings indicate an important ceiling effect, which prevented detection of improvement in terms of the external criteria in about 18% of the study patients.
Discussion
In this ambulatory population of consecutive patients with RA, the MHAQ, and to a lesser 19) (n = 11) (n = 26) (n = 8) (n = 10) (n = 37)
Disease activity physician (0-10) 6 we found a strong relationship between both the HAQ and the MHAQ and clinical parameters in the cross sectional assessment. However, only change in HAQ, not that in MHAQ scores, was significantly related to changes in clinical parameters in both non-parametric and parametric analyses. Several clinical parameters improved significantly for the group of patients with improved HAQ compared with the change in these parameters for the groups of patients with unchanged or worse HAQ scores at one year. The reason why the MHAQ did not distinguish patients who improved clinically from those who remained unchanged or worsened was probably a strong ceiling effect, which led to misclassification of patients as worsened or unchanged despite clinical improvement.
Our 
